Holen Sie sich die Stockscreener-App
6.19
0.98%
0.06
Vorhandelsmarkt:
6.29
0.10
+1.62%
Schlusskurs vom Vortag:
$6.13
Offen:
$6.22
24-Stunden-Volumen:
407.76K
Relative Volume:
0.45
Marktkapitalisierung:
$601.87M
Einnahmen:
$1.91M
Nettoeinkommen (Verlust:
$-94.23M
KGV:
-2.427
EPS:
-2.5505
Netto-Cashflow:
$-79.76M
1W Leistung:
+8.98%
1M Leistung:
+12.55%
6M Leistung:
+47.03%
1J Leistung:
+51.72%
1-Tages-Spanne:
$6.15
$6.36
1-Wochen-Bereich:
$5.50
$6.428
52-Wochen-Spanne:
$2.85
$6.9494
Anteris Technologies Global Corp Stock (AVR) Company Profile
Firmenname
Anteris Technologies Global Corp
Sektor
Telefon
651-493-0606
Adresse
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
6.19 | 601.87M | 1.91M | -94.23M | -79.76M | -2.5505 |
ISRG
Intuitive Surgical Inc
|
451.38 | 159.86B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.01B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 38.32B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 36.29B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.15B | 5.40B | 1.49B | 1.78B | 10.12 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2026-03-11 | Eingeleitet | Wells Fargo | Overweight |
| 2025-01-08 | Eingeleitet | Lake Street | Buy |
| 2025-01-07 | Eingeleitet | Barclays | Overweight |
| 2025-01-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-01-07 | Eingeleitet | TD Cowen | Buy |
Alle ansehen
Anteris Technologies Global Corp Aktie (AVR) Neueste Nachrichten
Anteris Technologies Enrolls First US Patients in PARADIGM Trial; Shares Up 6% - marketscreener.com
First U.S. patients enrolled in Anteris heart valve trial By Investing.com - Investing.com Canada
Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial - The Manila Times
Anteris Technologies begins U.S. enrollment in heart valve trial - StreetInsider
First U.S. patients enter Anteris heart valve trial for stenosis - Stock Titan
Anteris Sees CDI Decline as Investors Shift to Nasdaq-Listed Common Stock - TipRanks
AVR Stock Price, Quote & Chart | ANTERIS TECHNOLOGIES GLOBAL (NASDAQ:AVR) - ChartMill
Anteris Ends v2vmedtech Development Agreement, Limits Exposure - The Globe and Mail
Anteris Technologies Global Corp. (NASDAQ: AVR) registers 9.10M shares; discontinues v2v contributions - Stock Titan
Anteris Technologies Exits v2vmedtech Development Agreement, to Pay $400,000 Break Fee, Shares Up 3% - marketscreener.com
Anteris Walks Away From v2vmedtech Funding Deal With Limited Financial Impact - TipRanks
Anteris Technologies ends development agreement with v2vmedtech, pays $400,000 fee - Investing.com
Anteris Issues 110,236 Restricted Stock Units Under Employee Incentive Plan - TipRanks
Anteris Technologies Global (NASDAQ:AVR) Trading 5.7% HigherWhat's Next? - MarketBeat
Anteris Technologies Global CorpMilestone - Moomoo
Anteris Technologies Global Corp. Secures Cms Reimbursement Eligibility for Paradigm Trial - marketscreener.com
Anteris secures US Medicare coverage for PARADIGM Trial as DurAVR study advances - Proactive financial news
Anteris Wins CMS Reimbursement to Advance PARADIGM Heart Valve Trial in U.S. - TipRanks
Anteris Technologies (AVR) registers 9.10M-share resale; files 181K sq ft lease - Stock Titan
Anteris Technologies Expands Share Base via Conversion of Unquoted Securities - TipRanks
Anteris Technologies proposes $200M stock offering, plans Medtronic investment - MSN
Purchase/sale of business (net) of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Wells Fargo initiates coverage of Anteris Technologies Global (AVR) with overweight recommendation - MSN
ANTERIS TECHNOLOGIES GLOBAL CORP-ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT - Moomoo
Anteris Technologies Global Corp. (AVR) Files 8-K Announcing Material Definitive Agreement – Nasdaq-Listed Emerging Growth Company - Minichart
Anteris Technologies Global enters long-term lease for Minnesota facility By Investing.com - Investing.com India
Anteris Technologies Global prices $200M public offering and concurrent $90M Medtronic placement - MSN
Anteris Flags Material Agreement in SEC Filing as DurAVR Valve Advances - TipRanks
Anteris Technologies Signs Major Brooklyn Park Facility Lease - TipRanks
Anteris Technologies Global enters long-term lease for Minnesota facility - Investing.com
[8-K] Anteris Technologies Global Corp. Reports Material Event - Stock Titan
Anteris Technologies Looks Bullish If DurAVR's PARADIGM Delivers - Seeking Alpha
Anteris (AVR) Stock Watch: Key Levels (On the Radar) 2026-04-16Open Stock Signal Network - Cổng thông tin điện tử tỉnh Lào Cai
Anteris Technologies Global (NASDAQ:AVR) Trading Down 5.4%Here's What Happened - MarketBeat
Anteris Grants 20,000 Unquoted RSUs Under Employee Incentive Plan - TipRanks
US Market Wrap: Will Anteris Technologies Global Corp outperform small cap indexesWeekly Stock Report & Advanced Technical Signal Analysis - baoquankhu1.vn
Block Trades: Whats the analyst consensus on Anteris Technologies Global CorpTrade Volume Report & Entry and Exit Point Strategies - baoquankhu1.vn
Anteris Technologies Global Corp. (NASDAQ:AVR) Sees Large Growth in Short Interest - MarketBeat
Revenue Check: Is Anteris Technologies Global Corp benefiting from interest rate changesStock Surge & Accurate Trade Setup Notifications - baoquankhu1.vn
Anteris Technologies Seeks Quotation of Additional CDIs on ASX - TipRanks
Anteris Technologies Global (ASX:AVR) PB Ratio : (As of Apr. 11, 2026) - GuruFocus
AVR Options Volatility — NASDAQ:AVR - TradingView
AVR Options Chain — NASDAQ:AVR - TradingView
Published on: 2026-04-10 23:44:28 - baoquankhu1.vn
Anteris Technologies Global Corp at Barclays Global Healthcare Conference Transcript - GuruFocus
Aug Setups: How cyclical is Anteris Technologies Global Corps revenue streamProfit Target & Daily Profit Focused Stock Screening - baoquankhu1.vn
What upcoming catalysts matter for Anteris (AVR) Stock | Price at $5.41, Up 1.69%Trading Ideas - Cổng thông tin điện tử tỉnh Tây Ninh
Surprises Report: Is Anteris Technologies Global Corp a turnaround story2026 Highlights & Entry and Exit Point Strategies - baoquankhu1.vn
Anteris adjusts CDI and common stock balances through cross-market transfers - TipRanks
Anteris Technologies Global (NASDAQ:AVR) Trading Down 5.8%Should You Sell? - MarketBeat
A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market - Proactive financial news
Finanzdaten der Anteris Technologies Global Corp-Aktie (AVR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.78%
0.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):